Post by
Winston1 on Jun 12, 2022 3:32pm
Oftentimes valuations don't make sense, take advantage of it
In January 2021, Xebec was trading at over $11.50/share with a market cap of $1.75 billion. Their 2020 revenues were $56.5 million. That's an absurdly high 31X sales valuation. Today, Xebec is trading at 84 cents with a market cap of $130 million. Their 2021 revenues were $126 million. That's about a 1X sales valuation. Much more reasonable than last year, perhaps even unreasonably cheap. You decide.
Comment by
Gann999 on Jun 12, 2022 4:36pm
Is this compared to Anaergia who has proven they can make money on an ongoing basis by going from net income of 141k to 163k to negative 8.26m to negative 9.2m just asking why knock one company but praise another for doing the exact same thing.
Comment by
Winston1 on Jun 12, 2022 5:57pm
Bashers cherrypick data because they have a purpose to do so. They're either shorting it, bashing it to try to buy in at a lower price even though internet message boards have zero effect on the share price, or they're former disgruntled shareholders who bought high and sold low and are bitter at their mistake, look no further than lupuslupus as an example of that.